Accuracy of a screening tool for medication adherence: A systematic review and meta-analysis of the Morisky Medication Adherence Scale-8
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
BACKGROUND: This systematic review examined the reliability and validity of the Morisky Medication Adherence Scale-8 (MMAS-8), which has been widely used to assess patient medication adherence in clinical research and medical practice. METHODS: Of 418 studies identified through searching 4 electronic databases, we finally analyzed 28 studies meeting the selection criteria of this study regarding the reliability and validity of MMAS-8 including sensitivity and specificity. Meta-analysis for Cronbach's α, intraclass correlation coefficient (ICC), sensitivity and specificity to detect a patient with nonadherence to medication were performed. The pooled estimates for Cronbach's α and ICC were calculated using the random-effects weighted T transformation. A bivariate random-effects model was used to estimate pooled sensitivity and specificity. FINDINGS: The pooled Cronbach's α estimate for type 2 diabetes group in 7 studies and osteoporosis group in 3 studies were 0.67 (95% Confidence Interval(CI), 0.65 to 0.69) and 0.77 (95% CI, 0.72 to 0.83), respectively. With regard to test-retest, the pooled ICC for type 2 diabetes group in 3 studies and osteoporosis group in 2 studies were 0.81 (95% CI, 0.75 to 0.85) and 0.80 (95% CI, 0.74 to 0.85). For a cut-off value of 6, the pooled sensitivity and specificity in 12 studies were 0.43 (95% CI, 0.33 to 0.53) and 0.73 (95% CI, 0.68 to 0.78), respectively. CONCLUSIONS: The MMAS-8 had acceptable internal consistency and reproducibility in a few diseases like type 2 diabetes. Using the cut-off value of 6, criterion validity was not enough good to validly screen a patient with nonadherence to medication. However, this study did not calculated a pooled estimate for criterion validity using the higher values than 6 as a cut-off value since most of included individual studies did not report criterion validity based on those values.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The PHQ-8, MMAS, and the AAQ2 are widely used, with adequate reliability and validity (Bond et al., 2011; Moon et al., 2017; Villarreal-Zegarra et al., 2023).”
From Work-Related Cognitive Behavioral Therapy for racially and economically diverse unemployed persons with social anxiety: A randomized clinical trial (2024) · cites this paper as Moon et al., 2017
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Retracted: Predictive Validity of a Medication Adherence Measure in an Outpatient Setting
Morisky, D. E., Ang, A., Krousel‐Wood, M., & Ward, H. J. (2008) · The Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2008.07572.x · Cited by 2,877 · cited 14×
“Validation: Weon-Young Lee, Jin Seub Hwang, Donald E. Morisky.”
BackgroundMethodInfluentialSelf-citationRetractedPreferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.005 · Cited by 19,575
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies
Whiting, P. F., Rutjes, A. W. S., Westwood, M. E., Mallett, S., Deeks, J. J., Reitsma, J. B., Leeflang, M. M. G., Sterne, J. A. C., Bossuyt, P. M. M., & the QUADAS-2 Group* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-8-201110180-00009 · Cited by 14,199
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence
Morisky, D. E., Green, L. W., & Levine, D. M. (1986) · Medical Care · doi:10.1097/00005650-198601000-00007 · Cited by 5,317 · cited 1×
“developed a self-reported scale with 4 items regarding common medicationtaking behaviours leading to omission of drug [12].”
BackgroundSelf-citationKirk, J., MacDonald, A., Lavender, P., Dean, J., & Rubin, G. (2017) · Biomedicine Hub · doi:10.1159/000480347 · Cited by 3,887
Reitsma, J. B., Glas, A. S., Rutjes, A. W. S., Scholten, R. J. P. M., Bossuyt, P. M., & Zwinderman, A. H. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.02.022 · Cited by 3,369 · cited 1×
“Parameter estimates of this model are the summary receiver operating characteristics (SROC) curve, the summary operating point (summary values for sensitivity and specificity), a 95% confidence region around the summary operating point and a 95% prediction region based the cut-off 6 of common threshold [33].”
MethodOn the use, the misuse, and the very limited usefulness of Cronbach’s alpha
Sijtsma, K. (2009) · Psychometrika · doi:10.1007/s11336-008-9101-0 · Cited by 2,814
Cited by
Items 201–300 of 329
Yin, Z., Sun, R., He, R., Liu, H., Yuan, Z., Huang, T., Zhang, Z., & Zhao, J. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-082703 · Cited by 3
Borras-Gallen, A., Orozco‐Beltrán, D., Quesada, J. A., Carratalá‐Munuera, C., López‐Pineda, A., Nouni-García, R., & Pérez‐Jover, V. (2025) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2024.102439 · Cited by 3
Yu, J., Zhu, L., Song, Y., Shi, B., & Zhou, X. (2025) · Actas Españolas de Psiquiatría · doi:10.62641/aep.v53i3.1948 · Cited by 3
“Upon patients’ discharge, treatment compliance was assessed using the Morisky Medication Adherence Scale-8 (MMAS-8) [16].”
Khan, F. U., Khan, F. U., Wushouer, H., Shi, L., & Fang, Y. (2025) · Antibiotics · doi:10.3390/antibiotics14100977 · Cited by 3
Wondie, Y., Minwuyelet, A., Bogale, A., Hailu, G., & Mengstie, E. A. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-02023-x · Cited by 3
“According to the Morisky Medication Adherence Scale-8 (MMAS-8), patients were considered to have good adherence when they scored 8, medium adherence if they scored 6 to less than 8, and low adherence if they scored 6 [27].”
Artiles, J. V., Valdiande, J. J., Ospina, J. A., Costales, M., & Higuera, J. M. L. (2020) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22538 · Cited by 3
Non-Adherence Tree Analysis (NATA)—An adherence improvement framework: A COVID-19 case study
Edifor, E. E., Brown, R., Smith, P., & Kossik, R. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247109 · Cited by 3
“implemented, include pill count, patient questionnaire [14], self-report forms, and electronic monitoring devices.”
MethodShinzaki, S., Sakagami, K., Matsumoto, M., Takehara, T., & Ito, H. (2021) · Crohn s & Colitis 360 · doi:10.1093/crocol/otab081 · Cited by 3
“To evaluate drug adherence, the Morisky Medication Adherence Scales (MMAS)-8 score was used with permission.(8) High adherence was defined as an MMAS-8 score of 6 or more, and low adherence was defined as a score of less than 6.”
Data Deposit in a CKAN Repository: A Dublin Core-Based Simplified Workflow
Karimova, Y., Castro, J. A., & Ribeiro, C. (2019) · Communications in computer and information science · doi:10.1007/978-3-030-11226-4_18 · Cited by 3
Fibriana, A. I., Azam, M., Maryuni, S., Indrawati, F., Windraswara, R., & Turnbull, N. (2020) · Malaysian Journal of Public Health Medicine · doi:10.37268/mjphm/vol.20/no.2/art.307 · Cited by 4
Adherence to anticoagulation: an ongoing challenge
Seelig, J., & Hemels, M. E. W. (2019) · Netherlands Heart Journal · doi:10.1007/s12471-019-01347-3 · Cited by 3
Nurse Practitioner Guide to Achieving Medication Adherence Using the ADPIE Framework
McDermott, J. (2023) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2023.104791 · Cited by 2
Феликов, И. М., & Кашталап, В. В. (2024) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2024-6140 · Cited by 2
Yang, H., Xin, Y., Hu, X., Ma, K., Chen, P., Liu, X., Qian, Q., Hou, W., Zeng, F., Wang, G., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-093542 · Cited by 2
Minimum Core Data Elements for Evaluation of Thoracic Aortic Disease
Carbone, A., Roman, M. J., Russo, M. L., Holmes, K. W., Brown-Zimmerman, M. M., Elefteriades, J. A., Otto, C. M., Burris, N. S., Figueroa, C. A., DeRoo, S. C., et al. (2025) · JACC Advances · doi:10.1016/j.jacadv.2025.102001 · Cited by 2
TÉCUM: A New Transition Program for Young People With Epilepsy
Zhao, Y. N., Blondeau, L.-A., Drouin‐Engler, R., Beaudet, L., Côté, M., Damiani, J., Chartrand, D., Léger, V., Nguyen, D. K., Major, P., et al. (2025) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000200541 · Cited by 2
Bitterfeld, L., Brega, A. G., Dailey-Vail, J., Loresto, F., West, J., & Rael, C. T. (2025) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-025-02756-4 · Cited by 2
Coellar, J. D., Keshvani, N., Jain, A. K., Usman, M. S., Segar, M. W., Miller, J. W., Bustillo-Rubio, M., Kumbhani, D. J., Sathyamoorthy, M., Butler, J., et al. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2026.101499 · Cited by 2
“Medication adherence was evaluated using the 8-item Morisky Medication Adherence Scale (MMAS-8) [18], treatment satisfaction using the Treatment Satisfaction Questionnaire for Medication Version 1.4 (TSQM) [19,20], and quality of life using the Seattle Angina Questionnaire (SAQ) [21].”
InfluentialRana, R., Ibrahim, B., Huri, H. Z., Wahab, I. B. A., Govindaraju, K., Shukeri, M. S. M., & Ong, S. C. (2026) · Journal of Human Hypertension · doi:10.1038/s41371-026-01132-x · Cited by 3
“Additionally, the fi nal sample size was consistent with widely accepted guidelines for factor analysis, which recommend a respondent-to-item ratio of approximately 5 to 10 participants per item [26].”
Zhu, L., Lu, W., Liu, Z. E., Zhu, D., Yeh, M.-C., Nguyen, M. T., Tan, Y., Wang, M. Q., & Ma, G. X. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1681835 · Cited by 2
Mashhadiakbar, P., Hecker, M., Frahm, N., Baldt, J., Barhoum, B., Burian, K., Langhorst, S. E., Meißner, J., Streckenbach, B., Suntah, A. M., et al. (2026) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.71020 · Cited by 2
Razak, S. A., Makmor‐Bakry, M., Said, M. S. M., Tan, C.-E., & Redzuan, A. M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.572260 · Cited by 2
Abduljabbar, R., Tamimi, D. E., & Yousef, A. (2023) · Annals of Human Biology · doi:10.1080/03014460.2023.2173291 · Cited by 2
“Adherence to medications was assessed utilising the Morisky scale (Moon et al. 2017).”
MethodAdiwinoto, R. P., Putra, C. Y. L., Budiarti, R., Putra, O. N., Kresnamurti, A., & Sulistiawati, S. (2023) · Journal of Pharmaceutical And Sciences · doi:10.36490/journal-jps.com.v6i4.230 · Cited by 2
Wang, L., Fang, C., Nie, M., Zhu, L., Liu, S., & Li, H. (2024) · PubMed Central · doi:10.11817/j.issn.1672-7347.2024.240215 · Cited by 2
Zhou, J., Yang, X., Zhou, J., Xiong, M., & Li, W. (2024) · Journal of Asthma · doi:10.1080/02770903.2024.2410423 · Cited by 2
Evaluation of Impact of Pharmacists on Improving the Therapeutic Outcomes in Pediatrics
Anusha, M., Tejaswini, T., Akansha, A., Sravani, S., Desai, Y. D. Y., Fathima, Z. F. Z., Surve, A. M., & Sudhakar, M. (2025) · International Journal of Pharmaceutical Research and Applications · doi:10.35629/4494-100113051316 · Cited by 2
Reducing Racial Disparities in Hypertension Control Using a Multicomponent, Equity-Centered Approach
Kioko, S. M., & Tomori, C. (2025) · Health Equity · doi:10.1177/24731242251371424 · Cited by 2
“3,6,17,20,24 Practice and provider-level components addressed provider adherence to treatment guidelines and therapeutic inertia through standardized hypertension care processes and decision support tools.”
Abazimana, D., Okova, R., & Habtu, M. (2024) · Rwanda Journal of Medicine and Health Sciences · doi:10.4314/rjmhs.v7i2.4 · Cited by 1
“The instrument also measured adherence to hypertension medicatios using a scale adopted from the Morisky adherenc scale-eight points [14].”
MethodHamza, L. N., & Jallab, H. R. (2024) · Obat · doi:10.61132/obat.v2i5.679 · Cited by 1
Chebli, A. I., Chelighem, Z., Zebbiche, Y., Abdennour, S., Amziane, A., & Djidjik, R. (2024) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2024.10.010 · Cited by 1
Prescribing Pattern of Acute Coronary Syndrome in A Tertiary Care Hospital
Begum, S. Z., Fatima, U. K. A., Fatima, S., & Shareef, M. S. U. (2024) · International Journal of Pharmaceutical Sciences Review and Research · doi:10.47583/ijpsrr.2024.v84i10.002 · Cited by 1
Boachie‐Ansah, P., Anto, B. P., Marfo, A. F. A., Dassah, E. T., Asiamah, M., Mozu, I. E., Adomako, N. O., & Oppong, K. G. (2025) · Journal of Clinical Hypertension · doi:10.1111/jch.70005 · Cited by 1
Branisteanu, D. E., Munteanu, A. E., Dolofan, B., Popescu, E., & Vittos, O. (2025) · Life · doi:10.3390/life15030377 · Cited by 1
“The predictive value of the MMAS-8 has not been confirmed for selected outcomes in all studies [11,34,38].”
InfluentialDiagnostic and therapeutic care pathway of the Cardiac Network for Heart Failure
Palmiero, P., Durante, M., Maiello, M. R., D'andria, V., Caputo, C., & Giordano, L. (2025) · Italian Journal of Medicine · doi:10.4081/itjm.2025.1927 · Cited by 1
Scalable strategies for improving adherence in adults with hypertension—review
Egan, B. M. (2025) · Exploration of Medicine · doi:10.37349/emed.2025.1001298 · Cited by 1
Rayana, S., Pasupula, R., Keerthana, A., Sruthi, G. K., Suvarna, M., Noor, S. M., Pavani, P., Pedapudi, M., Sravani, G., & Chittelu, B. (2025) · Journal of Young Pharmacists · doi:10.5530/jyp.20251276 · Cited by 1
Autocuidado y estrés en pacientes mexicanos con diabetes mellitus tipo 2
Trujillo, M. G., Solórzano-Hernández, A. P. A. P., Durán, D. M. F., Serrano, N. I. C., Aguirre, G. L., & Briones-Aranda, A. (2024) · Revista de Salud Pública · doi:10.15446/rsap.v26n5.114261 · Cited by 1
Xia, J., Jinshu, H., Yanyan, M., & Zhe, J. (2025) · International Journal of Healthcare Information Systems and Informatics · doi:10.4018/ijhisi.384615 · Cited by 1
Li, J., Liu, Y., Xing, W., & Jiang, Y. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70119 · Cited by 1
Rosario, N., Davidson, D. A., & Bazaldua, O. V. (2025) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxaf254 · Cited by 1
Cahyadi, F. A., Agwa, M. M., & Ghozali, M. T. (2025) · International Conference on Electronic and Electrical Engineering and Intelligent System (ICE3IS) · doi:10.1109/ice3is66769.2025.11280922 · Cited by 1
“To assess medication adherence levels, the study utilized the Morisky Medication Adherence Scale, MMAS-8 [15] – a validated instrument widely used in clinical and community settings.”
Liu, M., Zhang, T., Guo, W., Chang, Y., Zhao, S., Zhang, M., & Zhang, L. (2026) · BMC Geriatrics · doi:10.1186/s12877-026-07131-4 · Cited by 2
“…of illness in older adults with hypertension, the type of medication taken, and whether the participants took the medication according to the doctor’s instructions (e.g., dosage and duration); the medication adherence scale developed by Morisky et al. [13] was used to assess medication adherence.”
Gupta, R., Gupta, K., Upadhyai, N., Mittal, A., & Ohri, P. (2026) · Preventive Medicine Research & Reviews · doi:10.4103/pmrr.pmrr_184_25 · Cited by 1
Parmar, J. S., McCaffery, K. J., Rahaman, K. S., Sidhu, B., Zachariah, D., Hng, T., Jayaballa, R., Wong, V. W., Hibbert, E., Turalic, U., et al. (2026) · Patient Education and Counseling · doi:10.1016/j.pec.2026.109737 · Cited by 1
Swift, E., Guðnadóttir, S. A., Haraldsdóttir, E. H., Hjartardóttir, H., Atladóttir, L. Ó., Helgadóttir, H. L., Gudmundsson, L. S., Sigurvinsdóttir, R., Ásbjörnsdóttir, K., & Gunnarsdóttir, J. (2026) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.70281 · Cited by 1
“19,20 To our knowledge, aspirin adherence in pregnancy has neither been estimated before with MMAS-8 nor has the instrument been validated in pregnancy.”
Kitamura, M., Ishikawa, K., Nei, K., Nakajima, K., Yamanoha, B., & Shimizu, A. (2018) · High Pressure Research · doi:10.1080/08957959.2018.1468442 · Cited by 2
de Família, M., Loureiro, R. M., de Azevedo, D. A., & de Família, M. (2021) · Revista Portuguesa de Clínica Geral · doi:10.32385/rpmgf.v37i4.12951 · Cited by 1
McDermott, J., Granger, B. B., Thompson, S., Baker, D., & D’Aoust, R. (2021) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2021.09.006 · Cited by 1
The role of compliance in the treatment of chronic heart failure and the ways to improve it
Meshcherina, N. S., Михайловна, Х. Е., Корниловна, Г. Н., Abrosimova, N. V., & Leontieva, T. S. (2021) · Человек и его здоровье · doi:10.21626/vestnik/2021-3/01 · Cited by 1
Usman, A., Yadav, R. R., Pagare, A., Ganguly, A., & Chakrabarti, R. (2023) · Apollo Medicine · doi:10.4103/am.am_176_22 · Cited by 1
“[23] The medication adherence was assessed using the MMAS‑8 questionnaire, which found acceptable internal consistency and reproducibility in patients with Type 2 DM. [24] The study identified 27.3% of the total population needs to remember to consume their medication on time.”
InfluentialTomić, N., Anđić, V., Ćurlik, D., Čeko, J., Avdić, A. T., Mehić, M., Šukalo, A., & Glamočlija, U. (2024) · European Journal of Orthopaedic Surgery & Traumatology · doi:10.1007/s00590-023-03786-6 · Cited by 1
“MMAS-8 is commonly used as a tool for measurement of adherence to therapy [36], however direct measurement of adherence has many benefits over indirect methods.”
Baigozhina, A., Umbetzhanova, A., Derbissalina, G., & Bekbergenova, Z. (2023) · Journal of Health Development · doi:10.32921/2225-9929-2023-1-50-35-44 · Cited by 1
Shahkaram, H., Sadeghi, A., Arani, A. M., Bakhtiari, M., & Kianimoghadam, A. S. (2024) · Gastroenterology and hepatology from bed to bench. · doi:10.22037/ghfbb.v17i3.2920 · Cited by 1
Chen, B., Xu, H., Shi, Y., Cheng, M., Chen, J., Su, X., Tang, H., Pan, D. A., & Yan, Q. (2025) · Scientific Reports · doi:10.1038/s41598-025-12567-6 · Cited by 1
“Medication adherence was assessed using the 8-item Morisky Medication Adherence Scale (MMAS-8), with scores < 6 indicating low adherence 18 .”
Paliy, I. G., Palii, D. V., Ksenchyn, O., Voinalovych, O., Vzhetson, T., & Morisky, P. M. (2025) · Family medicine European practices · doi:10.30841/2786-720x.3.2025.339928 · Cited by 1
ETDs, Research Data and More: The Current Status at Nanyang Technological University Singapore
Foo, S. S.-B., Zhang, X., Ruan, Y., & Goh, S. N. (2018) · Lecture notes in computer science · doi:10.1007/978-3-030-04257-8_37
Age‐related craniofacial differences based on spatio‐temporal face image atlases
Xavier, I. R. R., Giraldi, G. A., Gibson, S. J., Gattás, G. J. F., Rueckert, D., & Thomaz, C. E. (2019) · IET Image Processing · doi:10.1049/iet-ipr.2018.6271
Simulating Droplet Microfluidic Networks
Grimmer, A., & Wille, R. (2019) · Springer eBooks · doi:10.1007/978-3-030-20713-7_3
Dewi, I. P., Dewi, K. P., & Pinzon, R. T. (2020) · IOP Conference Series Earth and Environmental Science · doi:10.1088/1755-1315/441/1/012179
Réhospitalisations évitables du sujet âgé : identifier les personnes les plus à risque
Schwab, C. (2020) · theses.fr (ABES) · doi:10.70675/fdcc512eza799z4557z9502z39c8e47b5c06 · Cited by 1
Céspedes, E. E. A., Florido, A. F. A., Segovia, E. L., Solórzano, P. O., Lorenzo, S. M., Durán, S. A., & del Hierro, G. S. (2019) · Research Square · doi:10.21203/rs.2.13600/v1
“It has a sensitivity of 93% and specificity of 53%, in detection of therapeutic noncompliance.[17] It is a validated short questionnaire in patients with chronic diseases.”
BackgroundDa Porto, A. (2018) · The Journal of AMD · doi:10.36171/jamd18.21.1.03
Assessing Medication Adherence of Emergency Medicine Specialists Using the MMAS-8
Metin, D. A., & Kocataş, A. (2022) · Kafkas Journal of Medical Sciences · doi:10.5505/kjms.2022.67625
“The MMAS-8 is simple, and it is the most commonly used self-report method for determining the level of medication adherence 12–13 .”
Experimental Approaches and Generating the Evidence
Roughead, E. E., Dorj, G., & Lim, R. (2023) · Springer eBooks · doi:10.1007/978-3-030-50247-8_63-1
La qualité de vie dans les maladies auto-inflammatoires monogéniques
Touitou, I., Jeziorski, É., Al-Saleh, A., Carbasse, A., & Piram, M. (2023) · Revue du Rhumatisme · doi:10.1016/j.rhum.2023.04.014
A Systematic Review: Relationship Between Medication Adherence and Hypertension
Chan, M. (2023) · San José State University ScholarWorks (San Jose State University) · doi:10.31979/etd.rdha-b7a4
Phan, T. M., Nguyễn, D. C., & Pham, N. H. (2023) · Tạp chí Phẫu thuật và Tim mạch và Lồng ngực Việt Nam · doi:10.47972/vjcts.v43i.1013
Medication Adherence: Focus on Improvement
Haff, N., & Choudhry, N. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-88369-6.00031-1 · Cited by 1
Experimental Approaches and Generating the Evidence
Roughead, E. E., Dorj, G., & Lim, R. (2023) · Springer eBooks · doi:10.1007/978-3-030-64477-2_63
Simamora, L. S., Menaldi, S. L., Herqutanto, N., Miranda, E., & Bramono, K. (2023) · Preprints.org · doi:10.20944/preprints202311.1152.v1
Ávila, A. M., & Leyva-Jiménez, R. (2024) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2023.102178
Kably, B. (2022) · theses.fr (ABES) · doi:10.70675/0548aa9bz78e3z4bdfzb0e1z940e41d4f3ea
Jiang, T., Lee, Y.-X., Li, C., Wang, Y., Huang, Y., Wang, G., Wang, H., Zhao, F.-Y., & Zhang, W. (2024) · Research Square · doi:10.21203/rs.3.rs-4119690/v1
Goode, K., Pirbaglou, M., Grace, S. L., Katz, J. D., Henriques, D., & Ritvo, P. (2024) · doi:10.2196/preprints.60208
Assessment of Treatment Adherence in Chronic Heart Failure: A Narrative ReviewPreprint
Jelínek, L., Lazárová, M., & Václavík, J. (2024) · doi:10.22541/au.172516290.06830775/v1
The Interdisciplinary Stroke Team
Bottomley, S., & Sico, J. J. (2024) · Springer eBooks · doi:10.1007/978-3-031-66289-8_35
Alemu, G. S., Mengistu, S. B., Gedamu, Y., Ayele, E., Admas, H. A., Melese, E. B., Ayalew, D. G., & Legese, G. L. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-03708-2
“This finding is in line with a study con - ducted in China that found a statistically significant difference in the rate of response to NSBBs between groups with good and poor adherence (50.0% [37/74] versus 22.7% [5/22], P = 0.024) [2].”
InfluentialAkbar, H. G., Gallegos-Rejas, V. M., Dettrick, Z., Niumata, W., Taufatofua, N., Anderson, D. J., & Gallegos, D. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5200071
Souleymane, B., Daou, M., Almoustapha, H., Abdoulkader, A., Garba, A. A., Salifou, A. I., & Eric, A. O. (2025) · Open Journal of Internal Medicine · doi:10.4236/ojim.2025.152014
Saleye, M., Abdirahman, H., Assabe, T., & Libe, T. T. (2025) · medRxiv · doi:10.1101/2025.06.15.25329654
Saleye, M., Abdirahman, H., Assabe, T., & Libe, T. T. (2025) · Research Square · doi:10.21203/rs.3.rs-6865907/v1
Zhang, J., & Qu, J. Z. (2025) · medRxiv · doi:10.1101/2025.09.14.25335382
Sentuf, D. R., Jumrah, Idrus, H. H., Stang, & Darmawansyah (2025) · National Journal of Community Medicine · doi:10.55489/njcm.161020255672
Mazur, L., Батюх, О. В., & Mazur, P. Y. (2025) · Ukrainian Medical News · doi:10.32782/umv-2025.1.9
Mohammed-Jawad, N. K., Mikhael, E. M., & Alidrisi, H. A. (2025) · Al-Rafidain Journal of Medical Sciences · doi:10.54133/ajms.v9i2.2390
“Furthermore, the lack of reliability observed in type 1 diabetes is not surprising, as the Morisky Medication Adherence Scale—one of the most widely used tools for assessing medication adherence—has demonstrated variable reliability across different diseases and languages [26].”
Radić, J., Đogaš, H., Vučković, M., Gelemanović, A., & Radić, M. (2025) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2025.11.004
Patient perceptions and adherence to hypertension management plans: A cross-sectional study
Alanzi, T. M., Arif, W. M., Aloufi, N., Alnami, M., Al_Asiri, R., Alsharidah, W., Alqarni, B. A. A., Aldossary, M., Alhusaini, A., Abualqassim, F., et al. (2025) · Nutrition and Health · doi:10.1177/02601060251400244
Nguyen, B.-T. T. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/2cvr-nf59
Yang, H., Wu, F., Gui, M., Cheng, Y., & Zhang, L. (2023) · Figshare · doi:10.6084/m9.figshare.22617737
Yang, H., Wu, F., Gui, M., Cheng, Y., & Zhang, L. (2023) · Figshare · doi:10.6084/m9.figshare.22617734
Additional file 1 of Medication compliance of children with epilepsy: a cross-sectional survey
Wang, S., Zhang, X., Wang, Y., & Zhou, J. (2023) · Figshare · doi:10.6084/m9.figshare.24580298
Þórsdóttir, S. S. (2023) · Skemman
Espinoza Cristobal, L. A. (2022) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Феликов, И. М., & В., К. В. (n.d.) · CyberLeninK (CyberLeninka)
Ichsan, B., Herawati, E., Basuki, S. W., Pramudyatama, I. W., & Khoiriyah, U. (2025) · Journal of Health Research · doi:10.56808/2586-940x.1176
Wei, W., Wang, Y., Song, A., Kang, L., & Sun, J. (2025) · Psycho-Oncologie · doi:10.18282/po4355
Paliy, I. G., Palii, D. V., Ksenchyn, O., Voinalovych, O., Haiduk, O. А., Morisky, P. M., & Chernova, I. V. (2025) · Family medicine European practices · doi:10.30841/2786-720x.4.2025.349494
Padilla-López, J., Torres-Duque, L., Muñoz, S., Prado-Aguilar, C. A., Astudillo‐García, C. I., Moran, S., Martínez-Andrade, G. O., Vilchis‐Gil, J., & Duque, X. (2026) · BMC Family Practice · doi:10.1186/s12875-026-03199-4 · Cited by 1
“Patients were classified as having low adherence if their total score was < 6, medium adherence if the score ranged from 6 to 7, and high adherence if the score was 8 [39].”
Medication adherence rates in patients with ocular inflammatory disease
Chew, Z. R. J., Cheng, L.-Y. C., Agrawal, R. V., Ho, S. L., Wei, X., & Thng, Z. X. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1745392
“This approach was adopted to reduce discriminatory performance as prior evidence suggests that the traditional cuto of ≥ 6 demonstrates limited sensitivity and moderate specificity in identifying adherent patients (21).”
Metadata
- Authors
- Moon, S. J., Lee, W.-Y., Hwang, J. S., Hong, Y. P., & Morisky, D. E.
- Affiliations
- Chung-Ang University (KR)
- University of California, Los Angeles (US)
- Corresponding author
- Lee, Weon-Young
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-11-02
- Volume
- 12
- Issue
- 11
- Pages
- e0187139
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC5667769
- OpenAlex
- W2765324371
- Cited by
- 293
- References
- 43
- Citations by year
- 2026: 28 · 2025: 44 · 2024: 33 · 2023: 30 · 2022: 23 · 2021: 37 · 2020: 46 · 2019: 35 · 2018: 16 · 2017: 1
- FWCI
- 4.51
- Type
- journal article
- Language
- en
- Update notices
- correction (2018-04-17)
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Social Sciences › Sociology and Political Science › Survey Methodology and Nonresponse
- Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
- Keywords
- MMAS-8, medication adherence, adherence screening, psychometric properties, internal consistency, test-retest reliability, sensitivity and specificity, type 2 diabetes, osteoporosis, questionnaire validity
- MeSH terms
- Drug Therapy, Humans, Patient Compliance, Reproducibility of Results
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.